类固醇与免疫调节剂在心脏沙丘病症:一个系统性审查
Moiuz Chaudhri1, Brandon Goodwin1, Raviv Markovitz1
1Internal Medicine, Hackensack Meridian Health Ocean University Medical Center, Brick, USA.
Cureus
|April 14, 2025
概括
这项研究比较了心脏型硬化症 (CS) 的治疗方法,发现甲状腺素在减少心脏炎症方面是最有效的. 皮质类固醇仍然是标准的,但甲醇提供一种具有较少副作用的类固醇节约选择.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏类沙尔科病 (CS) 是一种严重的疾病,导致心力衰竭和心律失常.
- 皮质类固醇是标准的治疗方法,但免疫调节剂作为类固醇节省选择越来越受欢迎.
研究的目的:
- 系统地审查和比较皮质类固醇和免疫调节治疗对CS的有效性.
- 评估治疗对心肌炎炎症 (SUVmax) 和左心室喷射率 (LVEF) 的影响.
主要方法:
- 在2024年10月之前发表的11项研究 (观察性,病例系列,RCT) 的系统审查和元分析.
- 评估皮质类固醇,甲甲酸盐,因弗力西马布,利图西马布和组合药物.
- 分析SUVmax和LVEF作为主要疗效终点的变化.
主要成果:
- 所有治疗都显著降低了心肌炎症 (SUVmax).
- 甲托雷克萨特证明了降低SUVmax的最高效果大小 (d = 1.65,p < 0.001).
- 与皮质类固醇结合的因弗利克西马布也显示出显著的SUVmax降低 (d = 1.61,p < 0.001).
- 左心室喷射分数 (LVEF) 在不同组中略有改善;因弗力西马布和皮质类固醇显示最显著的LVEF增加 (d = 0.4,p = 0.05).
- 在SUVmax (p = 0.46) 或LVEF (p = 0.36) 的子组之间没有发现统计学上显著的差异.
结论:
- 皮质类固醇是已建立的CS的第一线治疗方法.
- 甲托雷克萨特显示出作为一种降低心肌炎症的类固醇节约剂的显著潜力.
- 因弗利西马布是有效的,但与感染风险相关;个性化治疗方案对于CS管理至关重要.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
321
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
321
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
147
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
147
01:26Heart Failure Drugs: Inotropic Agents
424
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
424
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
105
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
105
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
87
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
87